Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
What was the valuation of the Self-Injections Market in 2026, and what figure is it projected to hit by 2030?
The self-injections market size has experienced robust growth in recent years. It is projected to expand from $10.22 billion in 2025 to $11.04 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.1%. This historical expansion can be attributed to several factors, including the increasing prevalence of chronic diseases, the broader availability of injectable biologics, a growing preference for home-based treatment, the expansion of specialty pharmaceuticals, and improvements in injection device ergonomics.
The self-injections market size is projected to experience robust expansion in the coming years. This market is set to reach $15.05 billion by 2030, driven by a compound annual growth rate (CAGR) of 8.1%. Factors contributing to this growth during the forecast period include the escalating demand for self-care treatments, the increasing uptake of digital health-enabled injectors, the expansion of biologics development pipelines, a heightened emphasis on drug delivery solutions that improve adherence, and the expanding utilization of connected medical devices. Furthermore, key trends anticipated during this period encompass the growing adoption of auto-injector devices, an increasing requirement for wearable injection systems, the expanding application of self-administered biologic therapies, the development of more patient-focused drug delivery designs, and an intensified commitment to ensuring safety and precise dosing.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8235&type=smp
Which Drivers Are Affecting Market Participation In The Self-Injections Market?
The increasing prevalence of individuals with diabetes is projected to fuel the expansion of the self-injections market in the future. Diabetes is characterized by the pancreas, an organ responsible for insulin production, generating insufficient insulin, resulting in elevated blood sugar levels and potential severe health complications such as heart ailments, sight impairment, and renal disorders. Diabetic individuals can utilize self-injections to administer insulin and various other medications, thereby assisting in the maintenance of optimal blood sugar levels and preventing an accumulation of excess blood sugars at any moment, all without requiring professional medical assistance. As an illustration, a report in November 2025 by Diabetes Care, an international peer-reviewed medical journal based in the US, indicated that approximately 634.8 million adults, constituting 12.0 percent of the worldwide adult population, had impaired glucose tolerance in 2024. This figure is anticipated to rise to 846.5 million adults, or 12.9 percent of the global adult population, by the year 2050. Consequently, the rising count of diabetic patients is a primary force behind the expansion of the self-injections market.
What Segment Categories Are Covered In The Self-Injections Market?
The self-injections market covered in this report is segmented –
1) By Type: Devices, Formulations
2) By Dosage: Single Dose, Multi Dose
3) By Application: Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Pain Management, Other Applications
4) By Distribution Channel: Chemist, Online Pharmacies
Subsegments:
1) By Devices: Pre-Filled Syringes, Auto-Injectors, Microneedle Devices, Wearable Injectors
2) By Formulations: Biologics, Small Molecules, Combination Products
Which Trends Are Expected To Influence The Self-Injections Market In The Upcoming Years?
Leading companies in the self-injections market are prioritizing innovations in drug delivery, particularly hands-free, hidden-needle subcutaneous methods, to simplify the self-administration of large-volume biologics for patients. This hands-free, hidden-needle subcutaneous delivery refers to a wearable injector that delivers medication discreetly without manual effort, keeping the needle concealed for enhanced comfort and safety. As an illustration, in November 2023, Enable Injections Inc., a US-based drug-delivery technology company, secured its initial US Food and Drug Administration (FDA) approval for the enFuse large-volume wearable injector, to be used with EMPAVELI (pegcetacoplan). This compact, mechanical, body-worn system administers up to 25 mL subcutaneously, supporting both self-administration and in-clinic use with features like hands-free operation and minimal interruption to patients’ routines. The enFuse platform boosts convenience, facilitates home-based care, and generally improves the patient experience for the delivery of large-volume therapies.
Which Leading Companies Dominate The Self-Injections Market Share?
Major companies operating in the self-injections market are AbbVie Inc., Antares Pharma Inc., Baxter International Inc., Bayer AG, Becton Dickinson and Company, Bristol-Myers Squibb Company, Credence MedSystems Inc., Dali Medical Devices Ltd., Eli Lilly and Company, Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Merck & Co. Inc., Owen Mumford Limited, Pfizer Inc., PharmaJet Inc., Recipharm AB, Schott AG, SHL Group Limited, Terumo Corporation, West Pharmaceutical Services Inc., Wilhelm Haselmeier GmbH & Co. KG, Ypsomed Holding AG, APTAR PHARMA INDIA PVT LTD, Bespak Europe Ltd., Bioject Medical Technologies Inc., Catalent Inc., Crossject SA, Injex Pharma AG, Medeca Pharma AB, Medimop Medical Projects Ltd., Mylan N.V., Nemera Development S.A., Noble Medical Inc.
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/self-injections-global-market-report
Which Global Regions Are Shaping The Competitive Landscape Of The Self-Injections Market?
North America was the largest region in the self-injections market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the self-injections market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Self-Injections Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=8235&type=smp
Browse Through More Reports Similar to the Global Self-Injections Market 2026, By The Business Research Company
Injection Pen Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/injection-pen-global-market-report
Chemical Injection Pumps Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/chemical-injection-pumps-global-market-report
Chemical Injection Skids Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/chemical-injection-skids-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company